全球心脏即时检测试剂盒市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球心脏即时检测试剂盒市场 – 行业趋势及 2030 年预测

  • Medical Devices
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Cardiac Point Of Care Testing Kits Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1.50 Billion
Diagram Market Size (Forecast Year)
USD 3.22 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球心脏即时诊断试剂盒市场,按产品类型(心脏标志物测试、分析仪)、最终用户(研究实验室、医院、门诊手术中心、诊断实验室、其他)、处方模式(基于处方的测试、非处方测试)、分销渠道(直接招标、零售)划分 - 行业趋势和预测到 2030 年。

全球心脏即时诊断检测试剂盒市场

 心脏即时检测试剂盒市场分析及规模

政府增加对医疗基础设施建设的支出以促进先进的医疗设施是推动市场增长的关键因素,诊断这些疾病的需求不断增加、心脏病患者数量不断增加、生活方式的改变、传染病的增加以及新兴经济体的快速经济发展等因素也推动了心脏即时检测的发展。此外,医疗保健领域的技术进步和现代化的不断进步将在 2023 年至 2030 年期间为心脏即时检测试剂盒市场创造新的机会。

Data Bridge Market Research 分析,心脏即时检测试剂盒市场在 2022 年的规模为 15 亿美元,预计到 2030 年将达到 32.2 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 10.00%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

心脏即时检测试剂盒市场范围和细分  

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品类型(心脏标志物测试、分析仪)、最终用户(研究实验室、医院、门诊手术中心、诊断实验室、其他)、处方模式(基于处方的测试、非处方测试)、分销渠道(直接招标、零售)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S), Sekisui Diagnostics (U.S.), Trinity Biotech (Ireland), BIOMÉRIEUX (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S.), Beckman Coulter, Inc. (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Chembio Diagnostics, Inc. (U.S.), Quidel Corporation (U.S) and Sienco, Inc (U.S.)

Market Opportunities

  • Emerging underdeveloped regions with new developments and rising disorder

Market Definition

Cardiac POC is a type of medical test used to diagnose patients. Cardiovascular POCs are blood tests that include cholesterol and coagulation testing. These include tests for brain natriuretic peptides and troponin. Troponins are used to investigate a variety of cardiovascular conditions such as coronary syndromes, heart failures, and acute myocardial infarction. Troponin, lactate, dehydrogenase isoenzymes, and brain natriuretic peptides are cardiac POCs that aid enzyme detection during critical cardiac conditions.

Cardiac Point of Care Testing Kits Market Dynamics

Drivers

  • Enhance prevalence of chronic disorders 

The increasing number of disorders among the population as a result of changing modern lifestyles, dietary intake, obesity, and lack of exercise has resulted in an increase in the number of disorders and increased utilization of diagnostics kits, as well as increased efficiency of the diagnostic kits with increased test accuracy, drives the market of point care testing. Diabetes, oncology, cardiovascular disease, arthritis, respiratory disease, and many other chronic diseases Improved research and development with new technologies integrated in the medical sector, as well as the supply of needs required for curing patients' health with quick relief and results, all help to drive the market of cardiac point of care testing kits.

  • Developing infrastructure and health care facilities

Increased market demand for medical diagnostic kits, with increased technology and techniques for performing procedures in the laboratory or at home, as well as ease of access to medical devices for detecting the problem. Improved hospital health facilities with newly developed technologies, as well as improved research and technology with new launches by key market players, help to accelerate market growth.

Opportunities

  • Emerging underdeveloped regions with new developments and rising disorder 

Rapid acceptance of newly developed technologies in medical diagnostics for and enhancement testing with improved point-of-care testing with increased efficiency and accuracy of the test. Development of point-of-care testing across various regions, combined with increased demand for testing kits, drives the market to a greater extent, with increased market share during the forecast period.

Restraints/Challenges

  • The rising cost of the point care testing medical devices 

The rapid advancement of technologies in the market, as well as increased production and manufacturing of medical devices used in hospitals for the detection of various disorders with increased efficiency and accuracy of the testing kit, resulted in an increase in the cost of testing procedures with newly developed testing kits. Increased cost of medical diagnostic devices may pose a challenge to the market's ability to grow at a higher value.

This cardiac point of care testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac point of care testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cardiac Point of Care Testing Kits Market Scope

The cardiac point of care testing kits market is segmented on the basis of product type, end-user, prescription mode and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Cardiac Markers Test
  • Cardiac troponin (cTn) test
  •  Myoglobin test
  •  Creatine kinase MB isoenzyme (CK-MB) test
  •  Combinational test kits
  •  Brain natriuretic peptide (BNP) test
  • Analysers

 End-User

  • Research Laboratories
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others

Prescription Mode

  • Prescription Based Testing
  • Over-The-Counter Testing

 Distribution Channel

  • Direct Tenders
  • Retail

Cardiac Point of Care Testing Kits Market Regional Analysis/Insights

The cardiac point of care testing kits market is analyzed and market size insights and trends are provided by country, product type, end-user, prescription mode and distribution channel as referenced above.

The countries covered in the cardiac point of care testing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

北美占据心脏即时检测试剂盒市场的主导地位,因为北美拥有优惠的报销政策、完善的医疗基础设施以提供先进的医疗服务,且主要参与者遍布各国。

预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率,因为该地区政府在医疗保健方面的支出不断增加,以及该地区新兴经济体知名企业推出的创新产品。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

心脏即时检测试剂盒市场还为您提供了每个国家/地区资本设备医疗保健支出增长、心脏即时检测试剂盒市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对心脏即时检测试剂盒市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和心脏护理点检测试剂盒市场份额分析

心脏即时检测试剂盒市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对心脏即时检测试剂盒市场的关注有关。

心脏即时检测试剂盒市场的一些主要参与者包括:

  • 雅培(美国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • BD(美国)
  • 西门子医疗私人有限公司(德国)
  • Bio-Rad Laboratories, Inc.(美国)
  • 丹纳赫(美国)
  • Sekisui Diagnostics(美国)
  • Trinity Biotech(爱尔兰)
  • 生物梅里埃(法国)
  • EKF 诊断(德国)
  • AccuBioTech 有限公司 (中国)
  • 仪器实验室(美国)
  • 贝克曼库尔特公司(美国)
  • PTS Diagnostics(美国)
  • Nova Biomedical(美国)
  • Chembio Diagnostics, Inc.(美国)
  • Quidel Corporation(美国)
  • Sienco, Inc(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Cardiac Point of Care Testing Kits Market size will be worth USD 3.22 billion by 2030.
The Cardiac Point of Care Testing Kits Market growth rate is 10.00% by 2030.
Enhance prevalence of chronic disorders and Developing infrastructure and health care facilities are the growth drivers of the Cardiac Point of Care Testing Kits Market.
The product type, end-user, prescription mode, and distribution channel are the factors on which the Cardiac Point of Care Testing Kits Market research is based.
The major companies in the Cardiac Point of Care Testing Kits Market are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S), Sekisui Diagnostics (U.S.), Trinity Biotech (Ireland), BIOMÉRIEUX (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S.), Beckman Coulter, Inc. (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Chembio Diagnostics, Inc. (U.S.), Quidel Corporation (U.S) and Sienco, Inc (U.S.).